You are here

You are here

Heparin Science

The leading Heparin API manufacturer

Heparin is the most used anti-coagulant and anti-thrombotic drug in the world and Bioiberica’s history is closely tied to the molecule.

Since our founding in 1975, we understood that heparin was an essential active pharmaceutical ingredient for human health and it was important to be able to offer our customers the highest guarantees in safety, quality, and traceability.

Therefore, we are committed to specialisation and a deep knowledge of the molecule, which together with our business model based on vertical integration, have led us to the global leadership.

Heparine's Stories & News

23 May 2024

A crucial initiative to prevent shortages of critical medicines in the European Union.

28 Sep 2021

The 28th Symposium on Glycosaminoglycans, an internationally renowned scientific event focusing on glycosaminoglycans, will be sponsored by Bioiberica, which will also be present at the event as a global life sciences company specialising in the extraction and development of biomolecules for the pharmaceutical and nutraceutical industries.

4 Aug 2021
  • Bioiberica produces 20% of the world's Heparin API.
  • Heparin saves around a hundred million lives every year.
  • One out of every 5 doses of heparin administered in the world comes from Bioiberica.